Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Hematologic Malignancies · Solid Tumor, Adult

Farmatek

Zafatek

Farmatek patent portfolio — 53 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP HQ
1994 Founded
14 Employees
PMDA registrant Type
Company details
Status
Public
HQ
Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP
Founded
1994
Employees
14
Programs
26
Drugs
14
Patents
53
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Farmatek patents

53 pharmaceutical patents indexed for Farmatek. 0 expire within 24 months.

Farmatek has 53 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

53 patents

Patent portfolio

Page 1 of 2

  1. US 12419870

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12410403

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12398373

    Enhanced immune effector cells and use thereof

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12385012

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12281329

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12275955

    Combining iPSC derived effector cell types for immunotherapy use

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12264322

    Minimal volume reprogramming of mononuclear cells

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12247226

    Cellular reprogramming using temporal and transient plasmid vector expression system

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12203098

    Cells having solid tumor targeting backbone and use thereof

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12173274

    Enhanced immune effector cells and use thereof

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12156862

    Medicaments for the treatment of vasoconstriction related diseases or disorders

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12122846

    Chimeric antigen receptor for tumor targeting

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12036241

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11932870

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11851677

    Composition and methods for inducing myeloid suppressive cells and use thereof

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11730741

    6-chromanol derivatives for use as a medicament

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11634688

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11413309

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11365394

    Enhanced immune effector cells and use thereof

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11352607

    Genomic engineering of pluripotent cells

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11162075

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11162076

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11135244

    Stem cell culture media and methods of enhancing cell survival

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11096964

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11072781

    Genomic engineering of pluripotent cells

    Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11052118

    Enhanced stem cell composition

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11006626

    Compounds for protection of cells

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10980838

    Methods of treating ischemia

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10954529

    Minimal volume reprogramming of mononuclear cells

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10947505

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10927346

    Enhanced immune effector cells and use thereof

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10858628

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10851412

    Cell potency assay for therapeutic potential

    Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10676452

    Compound for the prophylaxis or treatment of organ damage

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10626372

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10426771

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10322124

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10287606

    Genomic engineering of pluripotent cells

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10172888

    Enhanced stem cell composition

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10123529

    Compounds for protection of cells

    Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10111907

    Methods of treating ischemia

    Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10023879

    Minimal volume reprogramming of mononuclear cells

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9943545

    Stem cell culture media and methods of enhancing cell survival

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9913841

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9873722

    Wnt compositions and therapeutic uses of such compositions

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9452186

    Enhanced stem cell composition

    Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9403885

    Wnt compositions and therapeutic uses of such compositions

    Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9370510

    Small molecule compounds to treat hearing loss

    Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Farmatek have?

53 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Farmatek patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.